Ignite Creation Date:
2024-05-06 @ 9:53 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03109002
Status:
COMPLETED
Last Update Posted:
2019-03-12
First Post:
2017-04-06
Brief Title:
An Epidemiology Study of Treatment Resistant Depression in the United States US
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Study Overview
Official Title:
Epidemiology of Treatment Resistant Depression in the US Analysis of Health Services Databases
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to describe the epidemiology of Treatment Resistant Depression TRD in the US including the population incidence of TRD and TRD as a proportion of Pharmacologically Treated Depression PTD and stratify the estimates by sex and age group with separate estimates for the Medicaid population the Medicare population and the privately insured population Anonymized participants data will be used for the analysis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RRA-18629 | OTHER | Janssen Research Development LLC | None |